BHST

40-F - BIOHARVEST SCIENCES INC. (0001723464) (Filer)

6-K - BIOHARVEST SCIENCES INC. (0001723464) (Filer)

VINIA's leadership position in the market validates its superior arterial dilation and blood flow performance as well as BioHarvest's Botanical Synthesis platform technologyVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 26, 2026) - BioHarvest Sciences Inc. (NASDAQ:BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a biotechnology company pioneering its proprietary Botanical Synthesis™ platform, today announced that its VINIA® brand has achieved the position of the #1 Resveratrol Polyphenol Nutraceutical Brand in the United States*.VINIA's leadership position is driven by its clinically demonstrated ability to increase arterial dilation, improving blood flow and enab

6-K - BIOHARVEST SCIENCES INC. (0001723464) (Filer)

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 17, 2026) - BioHarvest Sciences Inc. (NASDAQ:BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its proprietary Botanical Synthesis™ platform, today announced that it will report its fourth quarter and full year 2025 financial results after market close on Tuesday, March 31, 2026. The Company will host a conference call and webcast at 4:30 p.m. Eastern Daylight Time to discuss the results and provide an update on business operations.Fourth Quarter and Full Year 2025 Earnings CallDate: Tuesday, March 31, 2026Time: 4:30 PM Eastern TimeWebcast link: https://events.q4inc.com/attendee/512060117The Earnin

6-K - BIOHARVEST SCIENCES INC. (0001723464) (Filer)

6-K - BIOHARVEST SCIENCES INC. (0001723464) (Filer)

6-K - BIOHARVEST SCIENCES INC. (0001723464) (Filer)

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 5, 2026) - BioHarvest Sciences Inc. (NASDAQ:BHST) ("BioHarvest" or the "Company"), a leader in Botanical Synthesis technology, today announced that Mr. David Tsur will step down from its Board of Directors after more than four years of service. The Company further announced the appointment of Prof. Hezi Levy to its Board of Directors, effective immediately.Mr. Tsur has served on BioHarvest's Board since 2021 and has contributed meaningfully to the Company's strategic development and governance during a period of operational expansion, capital formation, product commercialization, and market positioning.Zaki Rakib, Chair

6-K - BIOHARVEST SCIENCES INC. (0001723464) (Filer)

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 3, 2026) - BioHarvest Sciences Inc. (NASDAQ:BHST) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to attend the 38th Annual Roth Conference taking place on March 22-24, 2026.CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional investors throughout the duration of the event. 38th Annual Roth Conference for Growth CompaniesDate: March 22-24, 2026Location: The Ritz-Carlton Laguna Niguel- Dana Point, CAFormat: 1x1 MeetingsSobel said: "I am pleased to announce our invitation to the 38th Annual Ro

Roth Capital initiated coverage of BioHarvest Sciences with a rating of Buy and set a new price target of $10.00

6-K - BIOHARVEST SCIENCES INC. (0001723464) (Filer)

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 7, 2026) - BioHarvest Sciences Inc., (NASDAQ:BHST) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology process, today issued a letter to shareholder partners from Chief Executive Officer, Ilan Sobel.Dear Fellow Shareholders,2025 marked an important milestone for BioHarvest Sciences: our first full year as a NASDAQ-listed company, and we enter 2026 with an annualized revenue run rate exceeding US$36 million and gross margins above 60%. It was a year of execution, validation, and capability -building across both of our complementary businesses — D2C Products and

AW - BIOHARVEST SCIENCES INC. (0001723464) (Filer)

POS AM - BIOHARVEST SCIENCES INC. (0001723464) (Filer)

6-K - BIOHARVEST SCIENCES INC. (0001723464) (Filer)

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 18, 2025) - BioHarvest Sciences Inc. (NASDAQ:BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a biotechnology company pioneering its proprietary Botanical Synthesis™ platform, today announced that it has been awarded a $1.6 million grant from the Israeli Innovation Authority (IIA). The grant was approved under the IIA's Bio-Convergence program, which supports technologies at the intersection of biology, engineering, data science, and artificial intelligence.The non-dilutive funding will support the development of new innovative capabilities for BioHarvest's second-generation Botanical Synthesis™ process, enabling t

6-K - BIOHARVEST SCIENCES INC. (0001723464) (Filer)

First Hydration Formula Powered by VINIA's Blood Flow Technology Enters the $13 Billion U.S. Electrolyte MarketVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 3, 2025) - BioHarvest Sciences Inc. (NASDAQ:BHST) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology platform, announces the U.S. launch of VINIA Blood Flow Hydration™, the first hydration solution powered by the blood flow benefits of VINIA's Piceid resveratrol to enter the $13 Billion US Electrolytes Drink Market*.Better Hydration Starts with Better Blood FlowFollowing overwhelmingly positive early-adopter interest, VINIA Blood Flow Hydration™ is n

Strong VINIA Momentum and New CDMO Win Delivers 39% Year-Over-Year GrowthCompany Fortifies Balance Sheet with Recent $19.9 Million Instiutional Equity Raise Following $14.7 Million Strengthening of Balance Sheet via Accelerated Warrant Exercises and Debt-to-Equity Conversions in SeptemberVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 13, 2025) - BioHarvest Sciences Inc. (NASDAQ:BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the third quarter ended September 30, 2025.Third Quarter 2025 Operational HighlightsAll figu

6-K - BIOHARVEST SCIENCES INC. (0001723464) (Filer)

6-K - BIOHARVEST SCIENCES INC. (0001723464) (Filer)

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 12, 2025) - BioHarvest Sciences Inc. (NASDAQ:BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to attend the Craig-Hallum 16th Annual Alpha Select Conference taking place on Tuesday, November 18th, 2025 in New York, NY. CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional investors throughout the event as shown below. Craig-Hallum 16th Annual Alpha Select ConferenceDate: Tuesday, November 18, 2025Format: 1x1 Meetings OnlyLocation: Sheraton New York Times Square Hotel | New

6-K - BIOHARVEST SCIENCES INC. (0001723464) (Filer)